FAAH inhibition ameliorates breast cancer in a murine model.
FAAH inhibition ameliorates breast cancer in a murine model.
复制标题
DOI:
10.18632/oncotarget.28534
复制
发表时间:
2023-10-31
期刊:
影响因子:
--
通讯作者:
Mohan, Chandra
中科院分区:
文献类型:
--
作者:
Tripathy, Mallika;Bui, Amy;Henderson, Jared;Sun, Jeffrey;Woods, Christian Rutan;Somani, Soumya;Doan, Thao;Louis Sam Titus, Anto Sam Crosslee;Mohan, Chandra
Breast cancer is the leading cancer among females worldwide. Disease outcome depends on the hormonal status of the cancer and whether or not it is metastatic, but there is a need for more efficacious therapeutic strategies where first line treatment fails. In this study, Fatty Acid Amide Hydrolase (FAAH) inhibition and endocannabinoids were examined as therapeutic alternatives. FAAH is an integral membrane enzyme that hydrolyzes endocannabinoids, rendering them inactive, and FAAH inhibition is predicted to increase cancer cell death. To test this, breast cancer cells were probed for FAAH expression using Western blot analysis, treated with FAAH inhibitors, exogenous endocannabinoids, and combinations of the two treatments, and assessed for viability. High levels of FAAH were observed in different breast cancer cell lines. FAAH inhibition was more effective than exogenous endocannabinoid treatment, and the combination of FAAH inhibitors and endocannabinoids was the most effective in inducing apoptosis of breast cancer cells in vitro. In addition, in vivo FAAH inhibition reduced breast cancer growth in immunodeficient mice. FAAH inhibition is a promising approach, and tremendous progress has been made in the field to validate this mechanism as an alternative to chemotherapy. Further research exploring the therapeutic potential and impact of FAAH expression on cancer cells is warranted.